Going back on Wegovy after a break: what actually happens

Restarting Wegovy after a break usually means re-titrating from a lower dose — your body needs time to readjust, even if you tolerated higher doses before.
Weight regain after stopping semaglutide is well-documented; restarting can help reverse it, but results vary and are not guaranteed.
The longer the gap, the more cautious your prescriber is likely to be about which dose to restart at.
A clinical review is needed before restarting, your prescriber will check your current weight, health status and any medicines you've started since stopping.

If you've stopped Wegovy and are thinking about restarting, you're not alone. Many people pause treatment — sometimes for surgery, sometimes because supply was patchy, sometimes simply because life got in the way. The short answer is that going back on Wegovy is generally possible, but your prescriber will almost certainly want you to re-titrate from a lower dose rather than pick up where you left off. Wegovy is a prescription-only medicine requiring clinical assessment before any course or restart, so a prescriber reviews your situation before treatment resumes.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Re-titration, side effects, and what your prescriber will look at before you restart

You've stopped, the weight has crept back (here's what's happening

You stopped Wegovy) maybe a planned pause before an operation, maybe the pen was out of stock for a month or two, or maybe you just needed a break. Now you're looking at the scales and recognising a pattern that the clinical evidence predicted. Research published in the STEP 1 trial in the New England Journal of Medicine showed that participants regained a significant portion of lost weight within a year of stopping semaglutide. That's not a personal failing; it reflects how appetite-regulating hormones behave once the medicine is no longer active.

The biology is fairly straightforward. Semaglutide acts on GLP-1 receptors involved in appetite and the feeling of fullness. When you stop, those signals quieten again, hunger returns, and energy intake tends to rise. Your body isn't broken; it's doing exactly what it was designed to do. Understanding that makes the decision to go back on Wegovy a practical one rather than an admission of defeat.

If you've noticed weight coming back after stopping Wegovy, the good news is that restarting does appear to restore the medicine's effect for most people. The key is how you restart, not just whether you do.

Why you'll almost certainly need to re-titrate, even if you were on 2.4mg before

This is the part many people don't expect. You spent months working up to a maintenance dose, tolerating each step well, and now you're being asked to go back to the beginning. It feels like lost ground, but the reasoning is sound. Your gastrointestinal system adjusts to semaglutide over time, and after a break of several weeks or more, that tolerance diminishes. Jumping straight back to a higher dose significantly increases the risk of nausea, vomiting and other GI effects.

How far back you restart depends on how long you've been off treatment. A gap of a few weeks might mean returning to the dose just below where you were. A gap of several months will typically mean starting again from 0.25mg. Your prescriber makes that call based on your specific history, not a one-size rule. This is one reason a clinical review before restarting matters rather than simply picking up a pen you have left over.

It's also worth noting that the Wegovy titration schedule (0.25mg, 0.5mg, 1.0mg, 1.7mg and up to 2.4mg (or, for eligible patients, the newer 7.2mg dose)) exists precisely to give your system time to settle at each level. Re-titration follows the same logic. Slow and steady here genuinely does lead to better tolerability. Pairing a restart with a conversation about injection technique can also help; the upper arm is a valid injection site if you've been rotating and find one area more comfortable than others.

What to watch for when the side effects come back

Restarting semaglutide from a lower dose usually means the GI side effects (nausea, loose stools, indigestion, fatigue) return in a milder form than they did the first time around. For most people they settle within a week or two of each dose step. That said, the pattern isn't identical for everyone, and a restart after a long gap can occasionally feel similar to first-time initiation.

Less commonly, people report symptoms like shaking or trembling when restarting, which is worth raising with your prescriber if it persists. And while most side effects are mild, the MHRA's Drug Safety Update guidance is clear that severe, persistent abdominal pain (particularly pain that spreads to the back) warrants prompt medical attention because of the known association with acute pancreatitis. That applies equally on a restart as it does on a first course.

Back pain specifically is something patients sometimes wonder about when restarting. If you're concerned, there's a detailed look at whether Wegovy can cause back pain and what the current evidence says. Report any unexpected or persistent symptoms to your prescriber, and you can also flag them directly using the Yellow Card scheme at yellowcard.mhra.gov.uk.

Starting the conversation with a prescriber

Going back on Wegovy starts with a consultation, not a repeat prescription click. A prescriber needs to know how long you've been off treatment, what your current weight is, whether your health has changed, and whether you've started any new medicines in the interim, some affect how semaglutide is absorbed or interacted with. If you were previously on treatment elsewhere, you'll likely be asked for evidence of that.

One practical note: if you're thinking about timing a restart around a pay cycle or a quieter spell at work, ordering before midday on a weekday means same-day clinical review and dispatch if approved, with next-working-day tracked delivery. It's not a small thing when you're trying to get back into a routine. Take a look at Wegovy pricing to understand what the private prescription cost covers before you go ahead.

The NHS semaglutide medicines page is also a useful reference for what the medicine is, how it works, and what to tell your GP if you're on it privately. Our clinical team at nume (sorry, at nume) reviews every consultation personally, and a restart is treated with the same care as a first prescription. When you're ready, start your free consultation and a prescriber will take it from there.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions